O. Kurmi (Coventry, United Kingdom), J. Soriano (Madrid, Spain)
Introduction
O. Kurmi (Coventry, United Kingdom), J. Soriano (Madrid, Spain)
|  |
Lung function trajectories based on annual measurements for 10 years in adults with airway obstruction
H. Backman (Umea, Sweden), A. Blomberg (Umea, Sweden), A. Lundquist (Umea, Sweden), V. Strandkvist (Lulea, Sweden), S. Sawalha (Umea, Sweden), U. Nilsson (Umea, Sweden), C. Stridsman (Umea, Sweden), L. Hedman (Umea, Sweden), E. Rönmark (Umea, Sweden), A. Lindberg (Umea, Sweden)
|    |
Multi-ancestry genetic risk score for lung function from meta-analysis of genome-wide association studies in 580,869 individuals from five ancestry groups
N. Shrine (Leicester, United Kingdom), A. Izqueirdo (Leicester, United Kingdom), J. Chen (Leicester, United Kingdom), A. Guyatt (Leicester, United Kingdom), R. Packer (Leicester, United Kingdom), C. Batini (Leicester, United Kingdom), A. Pozarickij (Oxford, United Kingdom), R. Walters (Oxford, United Kingdom), S. London (North Carolina, United States), A. Morris (Manchester, United Kingdom), L. Wain (Leicester, United Kingdom), I. Hall (Nottingham, United Kingdom), M. Tobin (Leicester, United Kingdom)
| |
Prevalence and risk factors for small airways obstruction: Results from the Burden of Obstructive Lung Disease (BOLD) study.
B. Knox-Brown (London, United Kingdom), J. Patel (London, United Kingdom), P. Burney (London, United Kingdom), A. Amaral (London, United Kingdom)
| |
Race-adjusted lung function increases inequities in diagnosis and prognosis and should be abandoned
M. Ekström (Lund, Sweden), D. Mannino (Lexington, United States)
| |
Plasma IgE and risk of exacerbation and mortality in COPD in the general population
Y. Çolak (Copenhagen, Denmark), T. S. Ingebrigtsen (Copenhagen, Denmark), B. G. Nordestgaard (Copenhagen, Denmark), J. L. Marott (Copenhagen, Denmark), P. Lange (Copenhagen, Denmark), J. Vestbo (Manchester, United Kingdom), S. Afzal (Manchester, United Kingdom)
| |
Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent post-diagnosis COPD exacerbations and mortality: a UK routine health care data study
H. Whittaker (London, United Kingdom), C. Nordon (Cambridge, United Kingdom), A. Rubino (Cambridge, United Kingdom), T. Morris (Luton, United Kingdom), Y. Xu (Luton, United Kingdom), E. De Nigris (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
| |
COVID-19 real-world data (RWD) insights regarding exacerbations and serum Eosinophil levels in Asthma and Chronic Obstructive Pulmonary Disease (COPD).
M. Cushion (Biggleswade, United Kingdom)
| |
Lung development genes, adult lung function and cardiovascular comorbidities
M. Talaei Pashiri (London, United Kingdom), L. Portas (London, United Kingdom), N. Aung (London, United Kingdom), M. Hind (London, United Kingdom), C. Dean (London, United Kingdom), C. Minelli (London, United Kingdom), S. Shaheen (London, United Kingdom)
| |
Factors associated with specific causes of death in a primary care COPD population in England
H. Whittaker (London, United Kingdom), K. Rothnie (London, United Kingdom), J. Quint (London, United Kingdom)
| |
Late Breaking Abstract - Beyond direct costs: Individual and societal burden of asthma in young adults
K. Håkansson (Copenhagen, Denmark), A. Løkke (Vejle, Denmark), R. Ibsen (Århus, Denmark), O. Hilberg (Vejle, Denmark), V. Backer (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark)
| |